Brief: Oncology Institute Q3 Revenue USD 99.9 Million
13/11/2024 21:05
Nov 13 (Reuters) - Oncology Institute Q3 net income USD -16.1 million. * Q3 gross profit USD 14.4 million
Recent news on Starling Oncology
See all newsBrief: Starling Oncology Unit Enters Credit Agreement On August 20
Brief: Starling Oncology Q2 EPS USD -0.08
Brief: Oncology Institute Rebrands As Starling Oncology
Oncology Institute Q1 revenue rises on specialty pharmacy growth, reaffirms 2026 revenue guidance
Brief: Oncology Institute Q1 Gross Profit USD 23.3 Million